(Q37738896)

22 August 2017

1 reference

title

Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease (English)

1 reference

22 August 2017

main subject

cardiovascular disease

1 reference

based on heuristic

inferred from title

author name string

Bernardo Rodriguez-Iturbe

series ordinal

1

1 reference

22 August 2017

Ricardo Correa-Rotter

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

28 April 2010

1 reference

Expert Opinion on Pharmacotherapy

22 August 2017

published in

1 reference

22 August 2017

volume

11

1 reference

22 August 2017

issue

16

1 reference

22 August 2017

page(s)

2687-2698

1 reference

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Cardiovascular disease and subsequent kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Chronic kidney disease: the global challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Prevalence of chronic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Diagnosing chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Chronic kidney disease and mortality risk: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Identifying patients with chronic kidney disease from general practice computer records

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Chronic kidney disease: effects on the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Relation of atrial fibrillation to glomerular filtration rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Renal function is associated with risk of atrial fibrillation after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Sudden cardiac death and dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Anemia: an early complication of chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Serum phosphate levels and mortality risk among people with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Relationship between homocysteine and mortality in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Suppression of renin-angiotensin gene expression in the kidney by paricalcitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

The need for optimal and coordinated management of CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Chronic kidney disease: why is current management uncoordinated and suboptimal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Clinical practice. Stage IV chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

How to prevent progression to end stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Chronic kidney disease and statins: improving cardiovascular outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Dyslipidemia in chronic kidney disease: managing a high-risk combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Primary prevention of type 2 diabetes mellitus by lifestyle intervention: implications for health policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Simple nutritional indicators as independent predictors of mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Body weight-for-height relationships predict mortality in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Moderate alcohol intake and renal function decline in women: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Risk of end-stage renal disease associated with alcohol consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Lifestyle modification and progressive renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Albuminuria in normals and essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Projected effect of dietary salt reductions on future cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Pathophysiological mechanisms of salt-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Benefits of dietary sodium restriction in the management of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Should diuretics always be included as initial antihypertensive management in early-stage CKD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Psychosocial aspects of chronic disease: ESRD as a paradigmatic illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Social support and chronic kidney disease: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

The importance of integrated risk management when treating patients with hypertension: benefits of angiotensin II receptor antagonist therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Analysis of multidisciplinary care models and interface with primary care in management of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Conceptual model of CKD: applications and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

The UK model for system redesign and chronic kidney disease services

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Which cardiovascular risk factors matter in chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003796570

10.1517/14656561003796570

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference